title: [Severe valvular heart disease associated with aplastic anemia--a successful case report of triple valve replacement].
abstract: A 59-year-old woman who suffered from valvular heart disease and aplastic anemia underwent triple valve replacement successfully. Aplastic anemia was effectively managed with prednisolone and mepitiostane pre-operatively. Post-operative course was almost satisfactory and blood analysis became normal under the medication of mepitiostane.
authors.forename: K
authors.initials: K
authors.lastname: Tsuchiya
authors.forename: M
authors.initials: M
authors.lastname: Aoki
authors.forename: M
authors.initials: M
authors.lastname: Kitamura
authors.forename: Y
authors.initials: Y
authors.lastname: Iida
authors.forename: N
authors.initials: N
authors.lastname: Chiba
mesh_terms: D000732:Androstanols / Q000008:administration & dosage; D000741:Anemia, Aplastic / Q000150:complications* / Q000188:drug therapy; D001021:Aortic Valve; D004359:Drug Therapy, Combination; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006801:Humans; D008875:Middle Aged; D008943:Mitral Valve; D011239:Prednisolone / Q000008:administration & dosage; D014261:Tricuspid Valve
chemical_list: D000732:Androstanols; D011239:Prednisolone; C006242:mepitiostane